The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

ACCC announces six winners of 2015 Innovator Awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

THE ASSOCIATION OF COMMUNITY CANCER CENTERS announced the six winners of its 2015 Innovator Awards.

This year’s winners are:

  • Eastern Maine Medical Center Cancer Program, for improving efficiency, safety and the patient experience with location technology.
  • Lancaster General Hospital and the Ann B. Barshinger Cancer Institute, for creating a Cancer Patient Support Fund for patients experiencing financial distress.
  • Mary Washington Healthcare Regional Cancer Center, for the center’s focused “prehabilitation” program that couples physical therapy with holistic care that includes nutritional support, stress reduction strategies and nurse navigator intervention, which decreased hospital length of stay for thoracic oncology patients by 40 percent.
  • PIH Health Comprehensive Community Cancer Program, for its nurse practitioner-run Lung Cancer Screening Program that utilizes an enrollment method that allows primary care practitioners to refer patients or for the patient to self-refer.
  • Providence Cancer Center, which offers a supportive group model to deliver early and ongoing intervention and support throughout cancer care and creating a framework to talk about the impact of cancer on the family.
  • The Seton Cancer Program of the Seton Family of Hospitals, for developing a standardized, integrated database of clinical and business metrics to measure, analyze and improve patient care and operational efficiency.

More details about each program are available on the ACCC website.

Table of Contents

YOU MAY BE INTERESTED IN

NCI Director's Report

Lowy: Forward-funding policy forced NCI to drastically reduce RPG awards funded for FY25, 10% of NCI staff has been lost

At the Sept. 4 meeting of the National Cancer Advisory Board, NCI Principal Deputy Director Douglas R. Lowy provided an overview of how NCI is weathering the maelstrom of executive orders, policy changes, and funding uncertainties that has come down on federal agencies and research institutes since Donald Trump’s inauguration in January. 
By Jacquelyn Cobb
Capitol Hill

With CDC in free fall, RFK Jr. faces bipartisan rebuke at Senate hearing
Kennedy calls CDC “the most corrupt agency at HHS and maybe the government.”

A Senate hearing that the administration hoped would be a routine check-in on the president’s 2026 MAHA-driven healthcare agenda erupted into a political firestorm as senators jumped at their first opportunity to confront HHS Secretary Robert F. Kennedy Jr. over the chaos engulfing the Centers for Disease Control and Prevention.
By Claire Marie Porter
Guest Editorial

Curing cancer or curbing immigration: A question of national morality and priority

In December 1971, President Richard Nixon signed the National Cancer Act and declared a “War on Cancer.” In the past 54 years, the U.S. has invested $180 billion nominally, or approximately $322 billion when adjusted for inflation, in cancer research. This investment has paid dividends with more than 100 anticancer drugs brought to market in half a century—virtually all traceable to National Cancer Institute funding. 
By Paul W. Thurman
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account